相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Interleukin-33 Drives a Proinflammatory Endothelial Activation That Selectively Targets Nonquiescent Cells
Jurgen Pollheimer et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2013)
Components of the interleukin-33/ST2 system are differentially expressed and regulated in human cardiac cells and in cells of the cardiac vasculature
Svitlana Demyanets et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2013)
The urokinase system in the pathogenesis of atherosclerosis
Bianca Fuhrman
ATHEROSCLEROSIS (2012)
Interleukin 33 as a Mechanically Responsive Cytokine Secreted by Living Cells
Rahul Kakkar et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
The urokinase receptor (CD87) represents a central mediator of growth factor-induced endothelial cell migration
Marina Poettler et al.
THROMBOSIS AND HAEMOSTASIS (2012)
Interleukin-33 Induces Expression of Adhesion Molecules and Inflammatory Activation in Human Endothelial Cells and in Human Atherosclerotic Plaques
Svitlana Demyanets et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2011)
Role of IL-33 in inflammation and disease
Ashley M. Miller
JOURNAL OF INFLAMMATION-LONDON (2011)
Extracellular matrix, inflammation, and the angiogenic response
Alicia G. Arroyo et al.
CARDIOVASCULAR RESEARCH (2010)
Pleiotropic Effects of Statins - Basic Research and Clinical Perspectives
Qian Zhou et al.
CIRCULATION JOURNAL (2010)
The urokinase receptor: Focused cell surface proteolysis, cell adhesion and signaling
Francesco Blasi et al.
FEBS LETTERS (2010)
ST2 gene expression is proliferation-dependent and its ligand, IL-33, induces inflammatory reaction in endothelial cells
Shinsuke Aoki et al.
MOLECULAR AND CELLULAR BIOCHEMISTRY (2010)
Disease-associated functions of IL-33: the new kid in the IL-1 family
Foo Y. Liew et al.
NATURE REVIEWS IMMUNOLOGY (2010)
Interleukin-33 induces angiogenesis and vascular permeability through ST2/TRAF6-mediated endothelial nitric oxide production
Yeon-Sook Choi et al.
BLOOD (2009)
Regulation of arterial remodeling and angiogenesis by urokinase-type plasminogen activator
Vsevolod A. Tkachuk et al.
CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY (2009)
New insights into the molecular mechanisms of the fibrinolytic system
D. C. Rijken et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2009)
IL-33 reduces the development of atherosclerosis
Ashley M. Miller et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2008)
The IL-33/ST2 pathway: therapeutic target and novel biomarker
Rahul Kakkar et al.
NATURE REVIEWS DRUG DISCOVERY (2008)
The Plasminogen Activator System and Cancer
Brandon McMahon et al.
PATHOPHYSIOLOGY OF HAEMOSTASIS AND THROMBOSIS (2007)
Pericellular proteases in angiogenesis and vasculogenesis
VWM van Hinsbergh et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2006)
Statins modulate expression of components of the plasminogen activator/plasmin system in human cardiac myocytes in vitro
S Demyanets et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2006)
IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines
J Schmitz et al.
IMMUNITY (2005)
Atherosclerotic plaque progression and vulnerability to rupture - Angiogenesis as a source of intraplaque hemorrhage
R Virmani et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2005)
Host-derived plasminogen activator inhibitor-1 (PAI-1) concentration is critical for in vivo tumoral angiogenesis and growth
K Bajou et al.
ONCOGENE (2004)
Association between plasmin activation system and intravascular ultrasound signs of plaque instability in patients with unstable angina and non-ST-segment elevation myocardial infarction
M Gyongyosi et al.
AMERICAN HEART JOURNAL (2004)
Intramural plasminogen activator inhibitor type-1 and coronary atherosclerosis
BE Sobel et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2003)
HMG CoA reductase inhibitors affect the fibrinolytic system of human vascular cells in vitro: a comparative study using different statins
F Wiesbauer et al.
BRITISH JOURNAL OF PHARMACOLOGY (2002)
分享论文
